MedImmune Message Board - Msg: 19586104

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MedImmune

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Larry Liebman who started this subject	12/11/2003 1:56:34 PM
From: Doc Bones	of 416

13:53 MEDI: CDC and Wyeth are in negotiations to acquire FluMist -- Leerink Swann (27.91 +0.51) Leerink Swann comments that the CDC and Wyeth are in negotiations to acquire FluMist. Once the CDC gains access to the vaccine, it would provide it to state agencies to help meet this year's heavy demand; firm says acquisition price or volumes for CDC negotiated FluMist are yet unknown; firm believes that by supplying the market with more vaccine, even at discounted prices, MedImmune may reap some benefit next season due to increased experience with the vaccine. What @#$^! discount. The CDC is short of vaccine. Time for a short squeeze! j/k ;-) Doc

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next